A A A
Onderzoek Publicaties 2006

2006

NTERNATIONALE WETENSCHAPPELIJKE PUBLICATIES (peer reviewed):

  • Anderson VM, Fox NC, Miller DH. Magnetic resonance imaging measures of brain atrophy in multiple sclerosis. J Magn Reson Imaging 2006;23:605-618.
  • Archer HA, Edison P, Brooks DJ, Barnes J, Frost C, Yeatman T, Fox NC, Rossor MN. Amyloid load and cerebral atrophy in Alzheimer’s disease: an 11 C-PIB positron emission tomography study. Ann Neurol 2006;60:145-147.
  • Archer HA, MacFarlane F, Price S, Moore EK, Pepple T, Cutler D, Frost C, Fox NC, Rossor MN. Do symptoms of memory impairment correspond to cognitive impairment: a cross sectional study of a clinical cohort. Int J Geriatr Psychiatry 2006;21:1206-1212.
  • Barkhof F, Scheltens Ph. Is the whole brain periventricular? J Neurol Neurosurg Psychiatry 2006;77:143-144.
  • Barnes J, Whitwell JL, Frost C, Josephs KA, Rossor M, Fox NC. Measurements of the amygdala and hippocampus in pathologically confirmed Alzheimer disease and frontotemporal lobar degeneration. Arch Neurol 2006;63:1434-1439.
  • Basile AM, Pantoni L, Pracucci G, Asplund K, Chabriat H, Erkinjuntti T, Fazekas F, Ferro JM, Hennerici M, O’Brien J, Scheltens P, Visser MC, Wahlund L-O, Waldemar G, Wallin A, Inzitari D, on behalf of the LADIS Study Group. Age, hypertension, and lacunar stroke are the major determinants of the severity of age-related white matter changes. Cerebrovasc Dis 2006;21:315-322.
  • Bastos-Leite AJ, van Waesberghe JH. Oen AL, van der Flier WM , Scheltens P, Barkhof F. Hippocampal sulcus width and cavities: comparison between patients withAlzheimer disease and niondemented elderly subjects. AJNR Am J Neuroradiol 2006;27:2141-2145.
  • Bastos Leite AJ, van der Flier WM, van Straaten ECW, Scheltens P, Barkhof F. Infratentorial abnormalities in vascular dementia. Stroke 2006;37:105-110
  • Biessels GJ, Koffeman A, Scheltens P. Diabetes and cognitive impairment. Clinical diagnosis and brain imaging in patients attending a memory clinic. J Neurol 2006;253:477-482.
  • Biessels GJ, de Leeuw F-E, Lindeboom J, Barkhof F, Scheltens P. Increased cortical atrophy in patients with Alzheimer’s disease and type 2 diabetes mellitus. J Neurol Neurosurg Psychiatry 2006;77:304-307.
  • Biessels GJ, Staekenborg S, Brunner E, Brayne C, Scheltens P. Risk of dementia in diabetes mellitus: a systematic review. Lancet Neurol 2006;5:64-74.
  • Biessels GJ, Staekenborg S, Brunner E, Brayne C, Scheltens P. Erratum : Risk of dementia in diabetes mellitus: a systematic review. (Lancet Neurol 2005;5:65-74.) Lancet Neurol 2006;5:113.
  • Bouwman FH, van der Flier WM, Scheltens P. Commentary: Can lumbar puncture help to identify patients with incipient Alzheimer’s disease? Nature Clinical Practice Neurology 2006;2:531.
  • Bouwman FH, van der Flier WM, Schoonenboom NSM, van Elk EJ, Kok A, Scheltens P, Blankenstein MA. Usefulness of longitudinal measurements of β-Amyloid 1-42 in cerebrospinal fluid of patients with various cognitive and neurologic disorders. Clin Chem 2006;52:1604-1606.
  • Boyes RG, Rueckert D, Aljabar P, Whitwell J, Schott JM, Hill DLG, and Fox NC. Cerebral atrophy measurements using Jacobian integration: comparison with the boundary shift integral. Neuroimage, 2006;32:159-169.
  • Camara O, Schweiger M, Scahill RI, Crum WR, Sneller BI, Schnabel JA, Ridgway GR, Cash DM, Hill DLG, Fox NC. Phenomenological model of diffuse global and regional; atrophy using finite-element methods. IEEE Trans Med Imaging 2006;25:1417-1430.
  • Camara-Rey O, Sneller BI, Ridgway GR, Garde E, Fox NC, Hill DLG. Simulation of acquisition artefacts in MR scans: effects on automatic measures of brain atrophy. Lecture Notes in Computer Science 2006;4190:272-280.
  • Camara-Rey O, Schweiger M, Scahill RI, Crum WR, Schnabel JA, Hill DLG, and Fox NC. Simulation of local and global atrophy in Alzheimer’s disease studies. Lecture Notes in Computer Science, 2006;4191:937-945.
  • Comijs HC, Dik MG, Rijmen F, Jonker C, van den Kommer TN, Deeg DJ. Vroege predictoren van dementie, de constructie van beslisbomen. Tijdschr Gerontol Geriatr 2006;37:237-242.
  • Cordonnier C, van der Flier WM, Sluimer JD, Leys D, Barkhof F, Scheltens P. Prevalence and severity of microbleeds in a memory clinic setting. Neurology 2006;66:1356-1360.
  • Damoiseaux JS, Rombouts SARB, Barkhof F, Scheltens P, Stam CJ, Smith SM, Beckmann CF. Consistent resting-state networks across healthy subjects. Proc Natl Acad Sci USA 2006;103:13848-13853.
  • Derksen E, Vernooij-Dassen M, Gillissen F, Olde Rikkert M, Scheltens P. Impact of diagnostic disclosure in dementia on patients and carers: qualitative case series analsis. Aging Mental Health 2006;10:525-531.
  • Derksen E, Vernooij-Dassen M, Scheltens P, Olde-Rikkert M. A model for disclosure of the diagnosis of dementia. Dementia 2006;5:462-468.
  • Dröes RM, Boelens-Van der Knoop EJ, Bos J, Meihuizen L, Ettema TP, Gerritsen DL, Hoogeveen F, Lange J de, Schölzel-Dorenbos C. Quality of life in dementia in perspective; an explorative study of variations in opinions among people with dementia and their professional caregivers, and in literature. Dementia: The International Journal of Social Research and Practice, 2006;5(4):533-558.
  • Dröes RM, Meiland FJ, Schmitz MJ, van Tilburg W. Effect of the Meeting Centres Support Program on informal carers of people with dementia: results from a multi-centre study. Aging Ment Health. 2006 Mar;10(2):112-24.
  • van Dijk KRA, Luijpen MW, van Someren EJW, Sergeant JA, Scheltens P, Scherder EJA. Peripheral electrical nerve stimulation and rest-activity rhythm in Alzheimer’s disease. J Sleep Res 2006;15:415-423.
  • van Es ACGM, van der Flier WM, Admiraal-Behloul F, Olofsen H, Bollen ELEM, Middelkoop HAM, Weverling-Rijnsburger AWE, Westendorp RGJ, Buchem MA van. Magnetization transfer imaging of gray and white matter in mild cognitive impairment and Alzheimer's disease. Neurobiol Aging 2006;27:1757-1762.
  • Ettema TP, Dröes RM, de Lange J, Mellenbergh GJ, Ribbe MW. QUALIDEM: development and evaluation of a dementia specific quality of life instrument--validation. Int J Geriatr Psychiatry. 2006 Oct 17; [Epub ahead of print]
  • Ewers M, Teipel SJ, Dietrich O, Schönberg SO, Jessen F, Heun R, Scheltens P, van de Pol L, Freymann NR, Moeller H-J, Hampel H. Multicenter assessment of reliability of cranial MRI. Neurobiol Aging 2006;27:1051-1059.
  • van der Flier WM, Schoonenboom SNM, Pijnenburg YAL, Fox NC, Scheltens, P. The effect of APOE genotype on clinical phenotype in Alzheimer’s disease. Neurology 2006;67:526-527.
  • Fox N. Structural neuroimaging outcomes in clinical dementia trials, with special reference to disease modifying. (Commentary) J Nutr Health Aging 2006;10:129-130.
  • Galimberti D, Schoonenboom N, Scheltens P, Fenoglio C, Venturelli E, Pijnenburg YAL, Bresolin N, Scarpini E. Intrathecal chemokine levels in Alzheimer disease and frontotemporal lobar degeneration. Neurology 2006;66:146-147.
  • Galimberti D, Schoonenboom N, Scheltens P, Fenoglio C, Bouwman F, Venturelli E, Guidi I, Blankenstein MA, Bresolin N, Scarpini E. Intrathecal chemokine synthesis in mild cognitive impairment and Alzheimer disease. Arch Neurol 2006;63:538.543.
  • Gauthier S, Reisberg B, Zaudig M, Petersen RC, Ritchie K, Broich K, Belleville S, Brodaty H, Bennett D, Chertkow H, Cummings JL, de Leon M, Feldman H, Ganguli M, Hampel H, Scheltens P, Tierney MC, Whitehouse P, Winblad B on behalf of the participants of the International Psychogeriatric Association Expert Conference on mild cognitive impairment. Mild cognitive impairment. Lancet 2006;367:1262-1270.
  • Godbolt AK, Waldman AD, MacManus DG, Schott JM, Frost C, Cipolotti L, Fox NC, Rossor MN. MRS shows abnormalities before symptoms in familial Alzheimer disease. Neurology 2006;66:718-722.
  • Godbolt AK, Beck JA, Collinge JC, Cipolotti L, Fox NC, Rossor MN. A second family with familial AD and the V717L APP mutation has a later age at onset. Neurology 2006;66:611-612.
  • Goekoop R, Scheltens P, Barkhof F, Rombouts SARB. Cholinergic challenge inAlzheimer patients and mild cognitive impairment differentially affects hippocampal activation - a pharmacological fMRI study. Brain 2006;129:141-157.
  • Goekoop R, Barkhof F, Duschek EJJ, Netelenbos C, Knol DL, Scheltens P, Rombouts SARB. Raloxifene treatment enhances brain activation during recognition of familiar items: a pharmacological fMRI study in healthy elderly males. Neuropsychopharmacology 2006;31:1508-1518.
  • Gootjes L, Bouma A, van Strien JW, Scheltens P, Stam CJ. Attention modulates hemispheric differences in functional connectivity: evidence from MEG recordings. Neuroimage 2006;30:245-253.
  • Gootjes L, Bouma A, van Strien JW, van Schijndel R, Barkhof F, Scheltens Ph. Corpus callosum size correlates with asymmetric performance on a dichotic listening task in healthy aging but not in Alzheimer's disease. Neuropsychologia 2006;44:208-217.
  • Gouw AA, van der Flier WM, van Straaten ECW, Barkhof F, Ferro JM, Baezner H, Pantoni L, Inzitari D, Erkinjuntti T, Wahlund LO, Waldemar G, Schmidt R, Fazekas F, Scheltens Ph. Simple versus complex assessment of white matter hyperintensities in relation to physical performance and cognition: the LADIS study. J Neurol 2006;253:1189-1196.
  • Grundman M, Petersen RC, Bennett DA, Feldman HH, Salloway S, Visser PJ, Thal LJ, Schenk D, Khachaturian Z, Thies W, for the Alzheimer’s Association Research Roundtable. Alzheimer’s association research roundtable meeting on mild cognitive impairment: what have we learned? Alzheimer’s & Dementia 2006;2:220-233.
  • van Harten B, Laman DM, van Duijn H, Knol DL, Stam CJ, Scheltens P, Weinstein HC. The auditory oddball paradigm in patients with vascular cognitive impairment: a prolonged latency of the N2 complex. Dement Geriatr Cogn Disord 2006;21:322-327.
  • van Harten B, de Leeuw FE, Weinstein HC, Scheltens P, Biessels GJ. Brain imaging in patients with diabetes: a systematic review. Diabetes Care 2006;29:2539-2548.
  • Hartley, SW, Scher AI, Korf ESC, White LR, Launer LJ. Analysis and validation of automated skull stripping tools: a validation study based on 296 MR images from the Honolulu Asia aging study. Neuroimage 2006;30:1179-1186.
  • Henley SMD, Frost C, Dipstat MA, MacManus DG, Warner TT, Fox NC, Tabrizi SJ. Increased rate of whole-brain atrophy over 6 months in early Huntington disease. Neurology 2006;67:694-696.
  • Irie F, Strozyk D, Peila R, Korf ES, Remaley AT, Masaki K, White LR, Launer LJ. Brain lesions on MRI and endogenous sex hormones in elderly men. Neurobiol Aging 2006;27:1137-1144.
  • Jones BF, Barnes J, Uylings HBM, Fox NC, Frost C, Witter MP, Scheltens P. Differential regional atrophy of the cingulate gyrus in Alzheimer disease; a volumetric MRI study. Cerebral Cortex 2006;16:1701-1708.
  • van der Knaap MS, Smit LME, Barkhof F, Pijnenburg YAL, Zweegman S, Niessen HWM, Imhof S, Heutink P. Neonatal porencephaly and adult stroke related to mutations in collagen IV A1. Ann Neurol 2006;59:504-511.
  • Korf ESC, White LR,.Scheltens Ph, Launer LJ. Brain aging in very old men with type 2 diabetes. Diabetes Care 2006;29:2268-2274.
  • Krishnan MS, O’Brien JT, Firbank MJ, Pantoni L, Carlucci G, Erkinjuntti T, Wallin A, Wahlund L-O, Scheltens P, van Straaten ECW, Inzitari D, on behalf of the LADIS group. Relationship between periventricular and deep white matter lesions and depressive symptoms in older people. The LADIS study. Int J Geriatr Psychiatry 2006;21:983-989.
  • Kropholler MA, Boellaard R, Schuitemaker A, Folkersma H, van Berckel BNM, Lammertsma AA. Evaluation of reference tissue models for the analysis of [11 C](R)-PK11195 studies. J Cereb Blood Flow Metab 2006;26:1431-1441.
  • Lazeron RHC, Killestein J, Rombouts SARB, Scheltens P, Barkhof F, Polman CH. Cannabis effects on brain activation in MS patients. A pilot study using fMRI. Neuroscience Imaging 2006;1:157-166.
  • Lazeron RHC, de Sonneville LMJ, Scheltens P, Polman CH, Barkhof F. Cognitive slowing in multiple sclerosis is strongly associated with brain volume reduction. Mult Scler 2006;12:760-768.
  • de Leeuw F-E, Korf E, Barkhof F, Scheltens P. White matter lesions are associated with progression of medial temporal lobe atrophy in Alzheimer disease. Stroke 2006;37:2248-2252.
  • Leow AD, Klunder AD, Jack CR, Toga AW, Dale AM, Bernstein MA, Britson PJ, Gunter JL, Ward CP. Whitwell JL, Borowski BJ, Fleisher AS, Fox NC, Harvey D, Kornak J, Schuff N, Studholme C, Alexander GE, Weiner MW, Thompson PM for the ADNI Preparatory Phase Study. Longitudinal stability of MRI for mapping brain change using tensor-based morphometry. Neuroimage 2006;31:627-640.
  • Madureira S, Verdelho A, Ferro J, Basile A-M, Chabriat H, Erkinjuntti T, Fazekas F, Hennerici M, O’Brien J, Pantoni L, Salvadori E, Scheltens P, Visser MC, Wahlund L-O, Waldemar G, Wallin A, Inzitari D, on behalf of the LADIS study. Development of a neuropsychological battery for the leukoaraiosis and disability in the elderly study (LADIS): experience and baseline data. Neuroepidemiology 2006;27:101-116.
  • Mijnhout GS, Scheltens P, Diamant M, Biessels GJ, Wessels AM, Simsek S, Snoek FJ, Heine RJ. Diabetic encephalopathy: a concept in need of a definition. Diabetologia 2006;49:1447-1448.
  • Montez T, Linkenkaer-Hansen K, van Dijk BW, Stam CJ. Synchronization likelihood with explicit time-frequency priors. Neuroimage 2006;33:1117-1123.
  • O’Brien JT, Firbank MJ, Krishnan MS, van Straaten ECW, van der Flier WM, Petrovic K, Pantoni L, Simoni M, Erkinjuntti T, Wallin A, Wahlund L-O, Inzitari D, on behalf of the Ladis Group. White matter hyperintensities rather than lacunar infarcts are associated with depressive symptoms in older people: the LADIS study. Am J Geriatr Psychiatry 2006;14:834-841.
  • Olde Rikkert MGM. van der Flier WM, de Leeuw FE, Verbeek M, Jansen RWMM, Verhey F, Scheltens Ph. Multiple diagnostic tests are needed to assess multiple causes of dementia. Arch Neurol 2006;63:144-146.
  • Oosterman JM, van Harten B, Weinstein HC, Scheltens P, Scherder EJA. Pain intensity and pain affect in relation to white matter changes. Pain 2006;125:74-81.
  • Pantoni L, Poggesi A, Basile AM, Pracucci G, Barkhof F, Chabriat H, Erkinjuntti T, Ferro JM, Hennerici M, O’Brien J, Schmidt R, Visser MC, Wahlund L-O, Waldemar G, Wallin A, Inzitari D on behalf of the LADIS Study Group. Leukoaraiosis predicts hidden global functioning impairment in nondisabled older people: the LADIS (Leukoaraiosis and disability in the elderly) study. J Am Geriatr Soc 2006;54:1095-1101.
  • Paviour DC, Price SL, Jahanshahi M, Lees AJ, Fox NC. Longitudinal MRI in progressive supranuclear palsy and multiple system atrophy: rates and regions of atrophy. Brain 2006; 129:1040-1049.
  • Paviour DC, Price SL, Jahanshahi M, Lees AJ, Fox NC. Regional brain volumes distinguish PSP, MSA-P, and PD: MRI-based clinico-radiological correlations. Mov Disord 2006;21:989-996.
  • Pijnenburg YAL, Schoonenboom SNM, Barkhof F, Knol DL, Mulder C, van Kamp GJ, van Swieten JC, Scheltens Ph. CSF biomarkers in frontotemporal lobar degeneration: relations with clinical characteristics, apolipoprotein E genotype, and neuroimaging. J Neurol Neurosurg Psychiatry 2006;77:246-248.
  • van de Pol LA, Hensel A, Barkhof F, Gertz HJ, Scheltens P, van der Flier WM. Hippocampal atrophy in Alzheimer disease: age matters. Neurology 2006;66:236-238.
  • van de Pol LA, Barkhof F, Scheltens P, van der Flier WM. Reply: Hippocampal atrophy in Alzheimer disease: age matters. Neurology 2006;67:728.
  • van de Pol LA, Hensel A, van der Flier WM, Visser PJ, Pijnenburg YAL, Barkhof F, Gertz HJ, Scheltens P. Hippocampal atrophy on MRI in frontotemporal lobar degeneration and Alzheimer’s disease. J Neurol Neurosurg Psychiatry 2006; 77:439-442.
  • Portet F, Ousset PJ, Visser PJ, Frisoni GB, Nobili J, Scheltens Ph, Vellas B, Touchon J, the MCI Working Group of the European Consortium on Alzheimer’s disease (EADC). Mild cognitive impairment (MCI) in medical practice: a critical review of the concept and new diagnostic procedure. Report of the MCI Working Group of the European Consortium on Alzheimer’s disease. J Neurol Neurosurg Psychiatry 2006;77:714-718.
  • Ridha BH, Barnes J, Bartlett JW, Godbolt A, Pepple T, Rossor MN, Fox NC. Tracking atrophy progression in familial Alzheimer’s disease: a serial MRI study. Lancet Neurol 2006;5:828-834.
  • Saczynski JS, Pfeifer LA, Masaki K, Korf ESC, Laurin D, White L, Launer LJ. The effect of social engagement on incident dementia; the Honolulu-Asia aging study. Am J Epidemiol 2006;163:433-440.
  • Scarpini E, Galimberti D, Guidi I, Bresolin N, Scheltens P. Progressive, isolated language disturbance: its significance in a 65-year-old-man. A case report with implications for treatment and review of literature. J Neurol Sci 2006;240:45-51.
  • Scheltens P, Barkhof F. Structural neuroimaging outcomes in clinical dementia trials, with special reference to disease modifying designs. J Nutr Health Aging 2006;10:123-130.
  • Scheltens P. Correction: Subcortical ischaemic vascular dementia: a separate disease entity? (J Neurol Neurosurg Psychiatry 2006;77:711). J Neurol Neurosurg Psychiatry 2006;77:804
  • Scherder E, Knol D, van Tol M-J, van Someren E, Deijen J-B, Swaab D, Scheltens P. Effects of high-frequency cranial electrostimulation on the rest-activity rhythm and salivary cortisol in Alzheimer’s disease. Dement Geriatr Cogn Disord 2006;22:267-272.
  • Schott JM, Ridha BH, Crutch SJ, Healy DG, Uphill JB, Warrington EK, Rossor MN, Fox NC. Apolipoprotein E genotypes modifles the phenotype of Alzheimer Disease. Arch Neurol 2006;63:155-156.
  • Schott JM, Frost C, Whitwell JL, MacManus DG, Boyes RG, Rossor MN, Fox NC. Combining short interval MRI in Alzheimer’s disease; implications for therapeutic trials. J Neurol 2006;253:1147-1153.
  • Schott JM, Kennedy J, Fox NC. New developments in mild cognitive impairment and Alzheimer’s disease. Curr Opin Neurol 2006;19:552-558.
  • Semplicini A, Amodio P, Leonetti G, Cuspidi C, Umiltà C, Schiff S, Scheltens P, Barkhof F, Emanueli C, Cagnin A, Pizzolato G, Macchini L, Realdi A, Royter V, Bornstein NM, Madeddu P. Diagnostic tools for the study of vascular cognitive dysfunction in hypertension and antihypertensive drug research. Pharmacol Ther 2006;109:274-283.
  • van Someren EJW. Mechanisms and functions of coupling between sleep and temperature rhythms. Prog Brain Res 2006;153:313-328.
  • van Someren EJW, Pticek MD, Speelman JD, Schuurman PR, Esselink R, Swaab DF. New actigraph for long-term tremor recording. Mov Disord 2006;21:1136-1143.
  • Spilt A, Goekoop R, Westendorp RGJ, Blauw GJ, de Craen AJM, van Buchem MA. Not all age-related white matter hyperintensities are the same: a magnetization transfer imaging study. AJNR Am J Neuroradiol 2006;27:1964-1968.
  • Stam CJ, Jones BF, Manshanden I, van Cappellen van Walsum AM, Montez T, Verbunt JPA, de Munck JC, van Dijk BW, Berendse HW, Scheltens P. Magnetoencephalographic evaluation of resting-state functional connectivity in Alzheimer’s disease. Neuroimage 2006;32:1335-1344.
  • van Straaten ECW, Fazekas F, Rostrup E, Scheltens P, Schmidt R, Pantoni L, Inzitari D, Waldemar G, Erkinjuntti T, Mäntylä R, Wahlund L-O, Barkhof F, on behalf of the LADIS Group. Impact of white matter hyperintensities scoring method on correlations with clinical data: the LADIS study. Stroke 2006;37:836-840.
  • Vernooij-Dassen M, Derksen E, Scheltens P, Moniz-Cook, E. Receiving a diagnosis of demenita. The experience over time. Dementia 2006;5:397-410.
  • Visser PJ, Brodaty H. MCI is not a clinically useful concept. Int Psychogeriatr 2006;18:402-409.
  • Visser PJ. Role of cognitive testing in disease modifying AD trials. J Nutr Health Aging 2006;10:131-132.
  • Visser PJ, Kester A, Jolles J, Verhey F. Ten-year risk of dementia in subjects with mild cognitive impairment. Neurology 2006;67:1201-1207.
  • van der Werf YD, Paus T. The neural response to transcranial magnetic stimulation of the human motor cortex. I. Intracortical and cortico-cortical contributions. Exp Brain Res 2006;175:231-245.
  • van der Werf YDr, Sadikot AF, Strafella AP, Paus T. The neural response to transcranial magnetic stimulation of the human motor cortex. II. Thalamocortical contributions. Exp Brain Res 2006;175:246-255.
  • Wessels AM, Rombouts SARB, Simsek S, Kuijer JPA, Kostense PJ, Barkhof F, Scheltens P, Snoek FJ, Heine RJ. Microvascular disease in type 1 diabetes alters brain activation; a functional magnetic resonance imaging study. Diabetes 2006;55:334-340.
  • Wessels AM, Simsek S, Remijnse PL, Veltman DJ, Biessels GJ, Barkhof F, Scheltens P, Snoek FJ, Heine RJ, Rombouts SARB. Voxel-based morphometry demonstrates reduced grey matter density on brain MRI in patients with diabetic retinopathy. Diabetologia 2006;49:2474-2480.

Vakpublicaties, boeken en ingezonden brieven

  • Dröes R-M, Meiland F, van Tilburg W. The meeting centres support programme model for persons with dementia and their carers: aims, methods and research. In: BML Miesen, GMM Jones.(eds), Care-giving in dementia. Research and appliactions vol. 4, 2006:315-339.
  • Fox NCI. Predicting the future by estimating the past: serial imaging in dementia. Inaugurele rede Amsterdam VU, 31 mei 2006.
  • Gauthier S, Scheltens Ph, Cummings JL (eds), Alzheimer's disease and related disorders annual 5. Boca Raton, Taylor & Francis, 2006. 214 pp.
  • Gauthier S, Scheltens P, Cummings JL. Enfermedad de Alzheimer y trastornos relacionados. Barcelona, Ars Medica, 2006. 212 pp.
  • Goekoop R. Farmacologische fMRI: een klinische verkenning? (Proefschriftbespreking) Tschr Neurol Neurochir 2006;107:95-97.
  • van Gool WA, Stam CJ, Steenhoek A, Hagemeijer A. Richtlijn ‘Diagnostiek en medicamenteuze behandeling van dementie’ Ned Tijdschr Geneeskd 2006;150:839-843.
  • Huyse FJ, van Dam EWCM, Pijnenburg YAL. Somatiek. In: RA Achilles, RJ Beerthuis, en WM van Ewijk (red.) Handboek spoedeisende psychiatrie. Amsterdam, Benecke N.I., 2006:505-526.
  • Kerssens CJ, Pijnenburg YAL, Schouws S, Eikelenboom P, van Tilburg W. Laat-ontstane schizofrenie: een dementia non-praecox? Tijdschr Psychiatrie 2006;48:717-727.
  • Kerssens CJ, Pijnenburg YAL, Schouws S, Eikelenboom P, van Tilburg W. Het ontstaan van psychotische verschijnselen op latere leeftijd; laat-ontstane schiofrenie of frontotemporale dementie? Tijdschr Psychiatrie 2006;48:739-744.
  • de Leeuw F-E, Kalaria R, Scheltens Ph. Treatment of vascular risk factors to delay Alzheimer’s disease ? In:Gauthier S, Scheltens Ph, Cummings JL (eds), Alzheimer's disease and related disorders annual 5. Boca Raton, Taylor & Francis, 2006. 153-163.
  • Pijnenburg YAL. Commentaar: Heterogeniteit van de ziekte van Alzheimer. HealthDirect Neurologie 2006;2(3):34.
  • Pijnenburg YAL. Commentaar: Oorzakelijk verband tussen mutaties in preseniline 1-gen en ziekte van Alzheimer. HealthDirect Neurologie 2006;2(2):31.
  • Pijnenburg YAL. Commentaar: Vasculaire factoren bij Alzheimer onderzocht. HealthDirect Neurologie 2006;2(3):30.
  • van Rhijn S, Pijnenburg Y. Veranderingen in gedrag en karakter: een neuropsychiatrisch beeld ten gevolge van neurodegeneratie. Neuropraxis 2006;10(2):50-54.
  • Scheltens Ph, Pijnenburg YAL. Niet-Alzheimer dementie: nosologie, diagnostiek en behandeling. In: Biemond Cursus :Cognitieve stoornissen, 17 maart te Arnhem en 8 december 2006 te Veldhoven Utrecht, Nederlandse Vereniging voor Neurologie, 2006:59-72.
  • Scheltens P, Barkhof F. Structural neuroimaging outcomes in clinical dementia trials, with special reference to disease modifying designs. In: B Vellas, LJ Fitten, B Winblad et al.(eds), Research and practice in Alzheimer’s disease vol. 11, 2006:71-83.
  • Schoonenboom N, Hampel H, Scheltens, P, De Leon M. Cerebrospinal fluid markers for the diagnosis of Alazheimer’s disease. In: S Gauthier, Ph Scheltens, and JL Cummings (eds), Alzheimer's disease and related disorders annual 5. Boca Raton, Taylor & Francis, 2006. 17-33.
  • Stam, C.J. Modern applications of electroencephalography in dementia diagnosis. In: Gauthier S, Scheltens Ph, Cummings JL (eds), Alzheimer's disease and related disorders annual 5. Boca Raton, Taylor & Francis, 2006. 191-206.
  • Stam CJ. Nonlinear brain dynamics. New York, Nova Science Publishers, 2006. 148 pp.
  • Tolboom, N, van der Flier, WM, van Schaik IN, Barkhof F, Scheltens Ph. Intracerebraal hematoom bij CADASIL: de rol van microbloedingen. Tschr Neurol Neurochir 2006;107:235-238.
  • Visser MC, Scheltens Ph. Vasculaire cognitieve achteruitgang en dementie. In: CL Franke M Limburg (red.), Handboek cerebrovasculaire aandoeningen. Utrecht, De Tijdstroom,2006:119-130.
  • Visser MC. Voorkomen en behandelen van complicaties. In: CL Franke M Limburg (red.), Handboek cerebrovasculaire aandoeningen. Utrecht, De Tijdstroom,2006:253-262.
  • Visser PJ. Lichte cognitieve achteruitgang: een klinisch entiteit ? Tschr Neurol Neurochir 2006;107:3-9.
  • Visser PJ. Role of cognitive testing in disease modifyiing AD trials. In: B Vellas, LJ Fitten, B Winblad et al.(eds), Research and practice in Alzheimer’s disease vol. 11, 2006:66-70.
  • Waldemar G, Dubois B, Emre M, Georges J, McKeith IG, Rossor M, Scheltens P, Tariska P, Winblad B. Alzheimer’s disease and other disorders associated with dementia. In: R Hughes, M Brainin, NE Gilhus (eds), European handbook of neurological management. Oxford, Blackwell Publishing, 2006. 266-298.

Dissertaties

  • Goekoop R. Pharmacological fMRI; - a clinical exploration. Enschede, PrintPartners Ipskamp, 2006. 256 pp. Proefschrift Amsterdam V.U. Promotoren: Ph Scheltens, F Barkhof, Copromotor: SARB Rombouts
  • van Harten B. Aspects of subcortical ischaemic vascular disease; early clinical manifestations and associations with Type 2 diabetes mellitus. Leeuwarden, Hellinga Grafische Specialisten, 2006. 116 pp. Proefschrift Amsterdam V.U. Promotor: Ph Scheltens Copromotor:Weinstein HC
  • Lazeron RHC. Functional and structural imaging in multiple sclerosis patients. Z. Pl., Z. Uitg., 2006. 230 pp. Proefschrift Amsterdam V.U. Promotoren: F Barkhof, Ph Scheltens, Copromotor: SARB Rombouts
  • Pelgrim-Korf ESC. Medial temporal lobe atrophy on MRI: vascular risk factors and predictive value for dementia. Enschede, PrintPartners Ipskamp BV, 2006. 144 pp. Proefschrift Amsterdam V.U. Promotoren:Ph Scheltens, F Barkhof, Copromotor: LJ Launer
  • Schoonenboom SNM. Cerebrospinal fluid markers for the early and differential diagnosis of Alzheimer’s disease. Enschede, PrintPartners Ipskamp BV, 2006. 187 pp. Proefschrift Amsterdam V.U. Promotoren:Ph Scheltens, MA Blankenstein, Copromotor: GJ van Kamp
Login naar de portal Stel een vraag Doneren

Onderzoek

Privacy | Disclaimer | © COZ Marketing 2010